Veradermics, Inc (MANE) SEC filings
MANENYSEPharmaceutical PreparationsFiscal year ends December 31
$135.29−21.27 (-13.59%)
Close on Nov 12, 2026Market cap $5.65BP/E –Yield –
SEC filings
15 of Veradermics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 10, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 10, 2026 | Nov 10, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 9, 2026 | Nov 9, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 19, 2026 | Oct 19, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 15, 2026 | Jul 15, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 12, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 12, 2026 | SEC EDGAR |
| Current report | 8-K | May 1, 2026 | May 1, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 27, 2026 | Apr 27, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 27, 2026 | Apr 27, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 30, 2026 | Mar 30, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 5, 2026 | Feb 5, 2026 | SEC EDGAR |
See a number that looks wrong?